Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq

🇺🇸 Investing.com (US) — 2026-10-09

Retension Pharmaceuticals priced its initial public offering at $12 per share on Nasdaq. The article provides no further details on the offering size or company operations.

Markets Deals Health Retension Pharmaceuticals IPO Nasdaq share pricing public offering biopharmaceuticals

Read original source →

Co-creator of Empire Market dark web marketplace given 40-year sentence
The Record by Recorded Future — 2026-10-10
Japan deal drought cuts IPO fundraising to lowest in 14 years
The Japan Times — 2026-10-09
Iran weighs US response as Trump rules out attack before midterms
Dawn Pakistan — 2026-10-09
Global banks bolster Japan debt teams as bond issuance booms
The Japan Times — 2026-10-09
Oil falls as Trump comments on Iran talks ease supply concerns
Channel NewsAsia — 2026-10-09
Dalaroo chases more gold after spectacular Côte d’Ivoire hit
The Sydney Morning Herald — 2026-10-09

Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq

AI Summary

Related Articles

Co-creator of Empire Market dark web marketplace given 40-year sentence

Japan deal drought cuts IPO fundraising to lowest in 14 years

Iran weighs US response as Trump rules out attack before midterms

Global banks bolster Japan debt teams as bond issuance booms

Oil falls as Trump comments on Iran talks ease supply concerns

Dalaroo chases more gold after spectacular Côte d’Ivoire hit